Literature DB >> 16737996

The usefulness of bone marrow aspiration in the diagnosis of Niemann-Pick disease type C in infantile liver disease.

A F Rodrigues1, R G Gray, M A Preece, R Brown, F G Hill, U Baumann, P J McKiernan.   

Abstract

BACKGROUND: Niemann-Pick disease type C (NPC) is a fatal, autosomal recessive lysosomal storage disease which may present in infancy with cholestatic jaundice and/or hepatosplenomegaly. In cholestatic patients with splenomegaly, a bone marrow aspirate has been advocated as a relatively accessible tissue to demonstrate storage phenomena. Typically in patients with NPC, macrophages with abnormal cholesterol storage, so called foam cells, can be detected in the bone marrow. AIM: To review our experience of bone marrow aspiration in children with NPC presenting with infantile liver disease.
METHODS: A retrospective analysis of 11 consecutive children (8 males) from Birmingham Children's Hospital with NPC presenting with infantile liver disease was undertaken. The diagnosis of NPC was confirmed in all cases by demonstrating undetectable or low rates of cholesterol esterification and positive filipin staining for free cholesterol in cultured fibroblasts.
RESULTS: The median age at presentation was 1.5 months (range 0.5-10). Bone marrow aspirates showed storage cells in only 7/11 cases. Bone marrow aspirates which had storage cells were undertaken at a median age of 11 months while those with no storage cells were undertaken at median age 2.3 months. The overall sensitivity of bone marrow aspirates for detecting storage cells in children presenting with infantile liver disease was 64%; however, for children who had bone marrow aspirates in the first year of life it was only 57%.
CONCLUSIONS: The sensitivity of bone marrow aspirate for the diagnosis of NPC disease in patients presenting with infantile liver disease was lower than previously reported. Where NPC is suspected clinically, definitive investigations should be undertaken promptly. There is a need to develop sensitive screening methods for NPC in children presenting with infantile liver disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16737996      PMCID: PMC2066037          DOI: 10.1136/adc.2005.088013

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  22 in total

Review 1.  Liver disease in infancy: a 20 year perspective.

Authors:  G Mieli-Vergani; E R Howard; A P Mowat
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

2.  Diagnosis of Niemann-Pick disease type C on chorionic villus cells.

Authors:  M T Vanier; R M Rousson; G Mandon; A Choiset; B D Lake; P G Pentchev
Journal:  Lancet       Date:  1989-05-06       Impact factor: 79.321

3.  Progression of neurovisceral storage disease with supranuclear ophthalmoplegia following orthotopic liver transplantation.

Authors:  J C Gartner; I Bergman; J J Malatack; B J Zitelli; R Jaffe; J B Watkins; B W Shaw; S Iwatsuki; T E Starzl
Journal:  Pediatrics       Date:  1986-01       Impact factor: 7.124

4.  Type C Niemann-Pick disease. Lysosomal accumulation and defective intracellular mobilization of low density lipoprotein cholesterol.

Authors:  J Sokol; J Blanchette-Mackie; H S Kruth; N K Dwyer; L M Amende; J D Butler; E Robinson; S Patel; R O Brady; M E Comly
Journal:  J Biol Chem       Date:  1988-03-05       Impact factor: 5.157

5.  Niemann-Pick disease group C: clinical variability and diagnosis based on defective cholesterol esterification. A collaborative study on 70 patients.

Authors:  M T Vanier; D A Wenger; M E Comly; R Rousson; R O Brady; P G Pentchev
Journal:  Clin Genet       Date:  1988-05       Impact factor: 4.438

6.  A progressive neurologic disorder with supranuclear vertical gaze paresis and distinctive bone marrow cells.

Authors:  F L Yan-Go; T Yanagihara; R V Pierre; N P Goldstein
Journal:  Mayo Clin Proc       Date:  1984-06       Impact factor: 7.616

7.  Linkage of Niemann-Pick disease type C to human chromosome 18.

Authors:  E D Carstea; M H Polymeropoulos; C C Parker; S D Detera-Wadleigh; R R O'Neill; M C Patterson; E Goldin; H Xiao; R E Straub; M T Vanier
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

8.  Clinical spectrum of Niemann-Pick disease type C.

Authors:  J K Fink; M R Filling-Katz; J Sokol; D G Cogan; A Pikus; B Sonies; B Soong; P G Pentchev; M E Comly; R O Brady
Journal:  Neurology       Date:  1989-08       Impact factor: 9.910

9.  Nonsyndromatic paucity of interlobular bile ducts: light and electron microscopic evaluation of sequential liver biopsies in early childhood.

Authors:  E Kahn; F Daum; J Markowitz; S Teichberg; L Duffy; R Harper; H Aiges
Journal:  Hepatology       Date:  1986 Sep-Oct       Impact factor: 17.425

Review 10.  Investigation of paediatric liver disease.

Authors:  D Kelly; A Green
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

View more
  4 in total

1.  Niemann-Pick disease type C in the newborn period: a single-center experience.

Authors:  Ersin Gumus; Goknur Haliloglu; Asuman Nur Karhan; Hulya Demir; Figen Gurakan; Meral Topcu; Aysel Yuce
Journal:  Eur J Pediatr       Date:  2017-09-27       Impact factor: 3.183

2.  Case Report: Be Aware of "New" Features of Niemann-Pick Disease: Insights From Two Pediatric Cases.

Authors:  Fan Chen; Shan Guo; Xuesong Li; Shengxuan Liu; Li Wang; Victor Wei Zhang; Hui Xu; Zhihua Huang; Yanqin Ying; Sainan Shu
Journal:  Front Genet       Date:  2022-03-11       Impact factor: 4.599

3.  The Presence of Vacuolated Kupffer Cells Raises a Clinical Suspicion of Niemann-Pick Disease Type C in Neonatal Cholestasis.

Authors:  Neng-Li Wang; Lian Chen; Yi Lu; Xin-Bao Xie; Jing Lin; Kuerbanjiang Abuduxikuer; Jian-She Wang
Journal:  Front Genet       Date:  2022-03-18       Impact factor: 4.599

Review 4.  Current Challenges in Understanding the Cellular and Molecular Mechanisms in Niemann-Pick Disease Type C1.

Authors:  Anja U Bräuer; Angela Kuhla; Carsten Holzmann; Andreas Wree; Martin Witt
Journal:  Int J Mol Sci       Date:  2019-09-06       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.